The COVID-19 virus has quickly spread across the globe, causing half a million cases and nearly 40,000 deaths. In the U.S., we’ve seen over 160,000 reported cases as of March 30, and the actual number is likely much higher. Disease is spreading rapidly, and health systems are struggling to keep pace. Across the country, non-essential businesses are being required to shut their doors, schools are closing—some for the remainder of the school year—, and state governors are issuing Stay-At-Home orders requiring that people not leave their homes unless absolutely necessary.
We are living in a new and uncertain reality. But to many, the fear and uncertainty surrounding COVID-19 is familiar. This is not the first time our society has experienced a pandemic like COVID-19; it is not the first time that people have been afraid to leave their homes, or that healthcare workers have struggled to keep pace with the number of cases.
By Aimee Pugh-Bernard, PhD
This post was originally published on April 4, 2013 and updated on March 17, 2020.
In the third installment of the Immunology 101 Series, Aimee explains the process of vaccine development. Vaccines undergo rigorous testing and must be proven extremely safe and effective before they are available for use in the general public.
As you may know from reading the first Immunology 101 Series post, vaccines train our immune systems to recognize and respond quickly to infection to keep us healthy. Reading the second Immunology 101 Series post, you learned that there are several different forms of vaccines, each created to produce the most effective vaccine possible based on the unique properties of each type of pathogen. In this post you will learn about the process of vaccine development. The process is lengthy and rigorous, just as it should be to prove that the end product is safe and effective! Read more
As kids gear up to go back to school, we're reminding parents to check immunization off their back-to-school checklist!
Measles outbreaks are popping up across the United States. From January 1 to March 7, 2019, 228** individual cases of measles have been confirmed in 12 states: California, Colorado, Connecticut, Georgia, Illinois, Kentucky, New Hampshire, New Jersey, New York, Oregon, Texas, and Washington. Six outbreaks (defined as 3 or more linked cases) have been reported, in Rockland County, New York; New York City, New York; Washington; Texas; California and Illinois.